Cargando…
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
BACKGROUND: Effective treatment of Mycobacterium tuberculosis (Mtb) infection requires at least 6 months of daily therapy with multiple orally administered antibiotics. Although this drug regimen is administered annually to millions worldwide, the impact of such intensive antimicrobial treatment on...
Autores principales: | Namasivayam, Sivaranjani, Maiga, Mamoudou, Yuan, Wuxing, Thovarai, Vishal, Costa, Diego L., Mittereder, Lara R., Wipperman, Matthew F., Glickman, Michael S., Dzutsev, Amiran, Trinchieri, Giorgio, Sher, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501520/ https://www.ncbi.nlm.nih.gov/pubmed/28683818 http://dx.doi.org/10.1186/s40168-017-0286-2 |
Ejemplares similares
-
Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques
por: Namasivayam, Sivaranjani, et al.
Publicado: (2019) -
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability
por: Namasivayam, Sivaranjani, et al.
Publicado: (2023) -
Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques
por: Sui, Yongjun, et al.
Publicado: (2018) -
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
por: Wipperman, Matthew F., et al.
Publicado: (2017) -
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
por: Namasivayam, Sivaranjani, et al.
Publicado: (2018)